Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling
Serena Stadler(Medical University of Vienna), Georg Krupitza(Medical University of Vienna), Mira Stadler(German Cancer Research Center), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Konstantin Alexander Brendel(Medical University of Vienna), Chi Huu Nguyen(University of Vienna), Julia Eichsteininger(University of Vienna), Benedikt Giessrigl(Medical University of Vienna), Olivier De Wever(Ghent University), Sigurd Krieger(Medical University of Vienna), Stefan Brenner(University of Vienna), Silvio Holzner(Medical University of Vienna), Daniela Milovanovic(Medical University of Vienna), Daniel Senfter(Comprehensive Cancer Center Vienna), Brigitte Marian(Comprehensive Cancer Center Vienna), Liselotte Krenn(University of Vienna), Helga Schachner(Medical University of Vienna), Wolfgang M. Schmidt(Medical University of Vienna), Robert M. Mader(Centre de Recherche en Économie et Management), Helmut Dolznig(Comprehensive Cancer Center Vienna), Nicole Huttary(Medical University of Vienna), Walter Jäger, Oskar Koperek(Medical University of Vienna)
Cited by 59
Related Papers
MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments
|Journal of Extracellular Vesicles|2020|514
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT/mTOR/S6-kinase signaling and drug response
|Journal of Cell Science|2016|392